KNSAKiniksa Pharmaceuticals, Ltd.Apr 28, 2026Q1 2026
Read transcript →Kiniksa Pharmaceuticals, Ltd. (KNSA) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$53.70
+2.69%
Mkt Cap $3.88B
KNSAKiniksa Pharmaceuticals, Ltd.Apr 28, 2026KNSAKiniksa Pharmaceuticals, Ltd.Feb 24, 2026Q4 2025
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Oct 28, 2025Q3 2025
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Jul 29, 2025Q2 2025
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Apr 29, 2025Q1 2025
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Feb 25, 2025Q4 2024
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Oct 29, 2024Q3 2024
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Jul 23, 2024Q2 2024
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Apr 23, 2024Q1 2024
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Feb 28, 2024Q4 2023
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Oct 31, 2023Q3 2023
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Jul 25, 2023Q2 2023
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.May 6, 2023Q1 2023
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Feb 28, 2023Q4 2022
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Nov 1, 2022Q3 2022
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Aug 5, 2022Q2 2022
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.May 7, 2022Q1 2022
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Feb 22, 2022Q4 2021
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Nov 1, 2021Q3 2021
Read transcript →KNSAKiniksa Pharmaceuticals, Ltd.Aug 3, 2021Q2 2021
Read transcript →